NRXP — NRx Pharmaceuticals, Inc.

NRXPNRx Pharmaceuticals, Inc.

NAS · US · Healthcare · Biotechnology · nrxpharma.com

4.290USD+33.23%Mkt Cap: 155.42M USDP/E: —Last update: 2026-05-26

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), an…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap155.42M USD

Enterprise Value105.08M USD

Revenue (TTM)2.29M USD

Gross Profit720.00K USD

Net Income (TTM)-28.62M USD

Revenue/Share0.0900 USD

Last Price4.290 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees29

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS6294441000

Valuation

P/E (Trailing)—

P/E (Forward)6.12

PEG—

EV/EBITDA-6.16

EV/Revenue45.83

P/S48.35

P/B-7.41

EPS (TTM)-1.04

EPS (Forward)0.50

52W Range

1.62095% of range4.440

52W High4.440 USD

52W Low1.620 USD

Profitability

Gross Margin58.78%

Oper. Margin-444.57%

EBITDA Margin0.00%

Profit Margin-2336.49%

ROE179.59%

ROA-220.92%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-14.11M USD

CapEx (TTM)—

FCF Margin-378.59%

FCF Yield-5.59%

Net Debt-5.78M USD

Net Debt/EBITDA0.34

Balance Sheet

Debt/Equity-0.04

Current Ratio0.29

Quick Ratio0.27

Book Value/Sh-0.4130 USD

Cash/Share0.1850 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateApr 2, 2024

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)40.40 USD

Target Range25.00 USD – 49.00 USD

# Analysts5

Ownership

Shares Out.36.23M

Float29.93M

Insiders7.58%

Institutions17.46%

Short Interest

Short Ratio4.3d

Short % Float14.08%

Short % Out.13.33%

Shares Short4.41M

Short (prev mo.)2.51M

Technical

SMA 502.574 (+66.7%)

SMA 2002.512 (+70.8%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)1.34M

Avg Vol (10d)1.20M

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—